Onayan, Rosemarie D.

HRN: 28-21-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2025
METRONIDAZOLE 500MG (TAB)
12/03/2025
12/13/2025
PO
500mg
TID
Intestinal Amoebiasis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: